Global Security Newswire
Daily News on Nuclear, Biological & Chemical Weapons, Terrorism and Related Issues
No-Needle Vaccination Tech Seen Bringing Biodefense Benefits
An emerging line of vaccination delivery mechanisms that do not use needles could offer advantages in responding to a possible intentional release of disease material, NBC News reported on Monday.
The systems -- now under development at various public, business and academic institutions -- could eventually offer a means of distributing treatments by postal delivery, according to NBC. They might retain their potency at room temperature, potentially making them less expensive and complicated to give out than the majority of conventional vaccinations.
“The early studies they have that are published give us an indication that it might result in a better response in a shorter amount of time than some of the current vaccines,” said Martin Crumrine, a biological defense expert with the National Institute of Allergy and Infectious Diseases.
“It’s much easier to give a tablet or two than it is to assemble people to give them injections,” Crumrine added.
The California-based biotechnology firm PaxVax is pursuing a pill-based alternative to the existing anthrax vaccination, which must be administered through five shots.
Nov. 8, 2013
This report is part of a collection examining implementation of United Nations Security Council Resolution 1540, which requires all states to implement measures aimed at preventing non-state actors from acquiring NBC weapons, related materials, and their means of delivery. It details implementation efforts in Central America, South America and the Caribbean to-date.
March 5, 2013
This article provides an overview of the United States’ historical and current policies relating to nuclear, chemical, biological and missile proliferation.